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Purpose: The aim of this study was to determine the effects
of co-treatment with the dietary phytochemical curcumin (de-
rived from Curcuma longa) and the polyphenolic phytoalexin
stilbene resveratrol (found in red grapes, red wine, peanuts and
some berries) on glycosaminoglycan (GAG) release from ex-
plants of canine articular cartilage challenged with lipopolysac-
charide (LPS).
Methods: Samples of canine articular cartilage were harvested
from the stifle joints and used to establish an ex vivo ex-
plant model. The explants were incubated in serum-free DMEM
medium containing antibiotics and challenged with LPS at con-
centrations of 0.25, 0.5, 1.25, 2.5 and 5 μg/ml thus creating a
model of joint inflammation. LPS stimulated samples and con-
trols were co-treated with either curcumin or resveratrol, both at
2.5 μM for a period of 5 days. The tissue culture medium and
the papain digested cartilage explants were analysed for GAG
content by the dimethylmethylene blue (DMMB) assay. LPS me-
diated GAG release into the culture medium was then expressed
as a percentage of the total GAG present in the explants prior to
experimentation.
Results: The DMMB assay confirmed the degradative effect of
LPS on canine cartilage explants. Challenge with LPS signifi-
cantly increased GAG release into the culture medium; increas-
ing the concentration of LPS increased GAG release in a dose
dependent manner. Co-treatment with 2.5 μM curcumin and 2.5
μM resveratrol antagonized the degradative actions of LPS and
decreased GAG release from the explants. GraphPad InStat soft-
ware was used for statistical analysis of data obtained with LPS
at 0.25 μg/ml (One-way ANOVA, Student-Newman-Keuls test).
There was a significant difference in GAG release between con-
trol and LPS stimulated samples (P<0.001). There was a marked
difference between the LPS stimulated samples with and without
2.5 μM resveratrol (P<0.001). Statistically significant differences
were also noted between the LPS stimulated samples with and
without 2.5 μM curcumin (P<0.001). The results are summarized
in Figure 1.
Fig. 1
Conclusions: We have shown for the first time that micromolar
concentrations of curcumin and resveratrol down-regulate the
catabolic and degradative effects of LPS, particularly its effects
on GAG release in explant cultures of canine articular carti-
lage. Therefore dietary phytochemicals and phytoalexin stilbenes
such as curcumin and resveratrol may have nutritional potential
as naturally occurring anti-inflammatory agents for treating os-
teoarthritis (OA). Future experiments will investigate the effects
of these compounds on the activity of inflammatory enzymes in-
cluding matrix metalloproteinases (MMPs) and cyclooxygenase 2
(COX-2) that modulate the catabolic status of articular cartilage.
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Purpose: The primary aim of this study was to investigate, using
an experimental rat model of osteoarthritis(OA), the effect of a se-
lective p38 mitogen activatedprotein kinase inhibitor,SB203580,
on the development of structural changes. Additional aims were
to assess the effects of the inhibitor on levels of matrixmetallopro-
teinase 3 (MMP-3) and MMP-13(collagenase 3) in OA cartilage
and to explore the relation between the MMP-3,13 expression
and the severity of OA.
Methods: OA was induced in 40 SD rats by anterior cruciate
ligament transection (ACLT). After surgical, rats with OA were
randomly divided into A_D groups: Rats of group A received 0.1
ml intra-articular injection of SB203580 at high oncentration of
100um/L. Each treatment started immediately after surgery, once
a week; those in group B were treated under the same condition
using SB203580 with low oncentration of 10um/L and those in
group C received 0.1ml of intra-articular 0.9% Sodium Chloride
injection, animals of group D were not injected as controls
after ACLT. The animals were killed 8 weeks after surgery.
Macroscopic and histological studies were performed on the
cartilage. The levels of MMP-3, 13 in OA cartilage chondrocytes
were evaluated by immunohistochemistry and western blotting.
Results: All ACLT knees demonstrated osteoarthritic changes.
Cartilage degradation in the control group was significantly sev-
erer than that in the experimental group both on the macroscopic
grading scale and on Mankin’s grading scale (P <0.05). Im-
munohistochemical study showed that in the experimental group
MMP-3, 13 was predominantly expressed in the superficial and
upper intermediate layers of cartilage, and the amount of MMP-3,
13 in the experimental group was also lower than that in con-
trol group(P <0.05). In western blotting, the amount of MMP-3,
13 was reduced by the treatment of the inhibitor. The protein
levels of MMP-3 and MMP-13 in cartilage of inhibitor injection
groups were significantly lower than those of Sodium Chloride
group and untreated group. There was no significant difference
in MMP-3 and MMP-13 expression between the different con-
centration inhibitor injection groups. No significant difference in
MMP-3 and MMP-13 expression in cartilage was found between
Sodium Chloride group and control group.
Conclusions: This study demonstrates that, in vivo, SB203580,
a selective inhibitor of p38MAPK, can partially decrease the de-
velopment of some of the structural changes in the early phases
of experimental OA and significantly reduces the severity of car-
tilage degradation. This effect was associated with a reduction in
the level of MMP-3,13 in OA cartilage, which probably explains
the action of the drug and thus may be a potential drug for the
treatment of OA.
